POOLBEG PHARMA PLC Stock Price, News & Analysis
Company Description
POOLBEG PHARMA PLC (OTC Link: POLBF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $43.4M.
POLBF stock has gained 42.4% over the past year. Shares last traded at $0.0598.
This page provides a comprehensive overview of POLBF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
POOLBEG PHARMA PLC (POLBF) stock last traded at $0.0598. Over the past 12 months, the stock has gained 42.4%. At a market capitalization of $43.4M, POLBF is classified as a micro-cap stock with approximately 697.2M shares outstanding.
Latest News
POOLBEG PHARMA PLC has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include management, acquisition. View all POLBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in POOLBEG PHARMA PLC (POLBF) currently stands at 2.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. The 6.0 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for POOLBEG PHARMA PLC (POLBF) currently stands at 6.0 days, down 57.9% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 20.2% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 5.0 to 14.3 days.
POLBF Company Profile & Sector Positioning
POOLBEG PHARMA PLC (POLBF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing POLBF often look at related companies in the same sector, including Relief Hldg (RLFTF), Relief Therapeut (RLFTY), Covalon Technologies Ltd (CVALF), Sernova Biotherapeutics Inc (SEOVF), and Zivo Bioscience Inc (ZIVO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate POLBF's relative position within its industry.